S&P ASX All Technology

US Dollar vs AUD

Register for real-time alerts, custom portfolio, and market movers

Get Started

RNA Avidity Biosciences Inc

23.78

-1.31 (-5.22%)

Last Updated: 03:25:06

Delayed by 15 minutes

Avidity gains as SVL Leerink touts its candidate for rare muscle disorder

To read the full story on Seeking Alpha, click here.

Avidity Biosciences (NASDAQ:RNA)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Avidity Biosciences Charts.

Avidity Biosciences (NASDAQ:RNA)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Avidity Biosciences Charts.

Avidity Biosciences Inc News

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 23 April 2024 (3 days ago) • PR Newswire (US)

Avidity Biosciences to Participate in Upcoming Investor Conferences
Thursday 28 March 2024 (4 weeks ago) • PR Newswire (US)

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 22 March 2024 (1 month ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial
Monday 4 March 2024 (2 months ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Avidity Biosciences Honors Rare Disease Day®
Friday 1 March 2024 (2 months ago) • PR Newswire (US)

Avidity Biosciences Announces Oversubscribed $400 Million Private Placement
Thursday 29 February 2024 (2 months ago) • PR Newswire (US)

More Avidity Biosciences Inc News Articles

Woodside Petroleum

Sterling vs AUD

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions